89bio (NASDAQ:ETNB) Earns Neutral Rating from Analysts at The Goldman Sachs Group
Equities researchers at The Goldman Sachs Group assumed coverage on shares of 89bio (NASDAQ:ETNB – Get Free Report) in a report released on Friday, MarketBeat.com reports. The firm set a “neutral” rating and a $11.00 price target on the stock. The Goldman Sachs Group’s price objective suggests a potential upside of 29.87% from the company’s […]
Equities researchers at The Goldman Sachs Group assumed coverage on shares of 89bio (NASDAQ:ETNB – Get Free Report) in a report released on Friday, MarketBeat.com reports. The firm set a “neutral” rating and a $11.00 price target on the stock. The Goldman Sachs Group’s price objective suggests a potential upside of 29.87% from the company’s […]
